Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker ELTX
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 13, 2026 | ELTX Elicio Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Nov 5, 2026 | ELTX Elicio Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 14, 2026 | ELTX Elicio Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 14, 2026 | ELTX Elicio Therapeutics, Inc. | 5.08 Shareholder Director Nominations | 8-K | 8-K ↗ |
| Aug 13, 2026 | ELTX Elicio Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 2, 2026 | ELTX Elicio Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 2, 2026 | ELTX Elicio Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 24, 2026 | ELTX Elicio Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 17, 2026 | ELTX Elicio Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 15, 2026 | ELTX Elicio Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 11, 2026 | ELTX Elicio Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 16, 2026 | ELTX Elicio Therapeutics, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 16, 2026 | ELTX Elicio Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 12, 2026 | ELTX Elicio Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 13, 2025 | ELTX Elicio Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 17, 2025 | ELTX Elicio Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 17, 2025 | ELTX Elicio Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 12, 2025 | ELTX Elicio Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 7, 2025 | ELTX Elicio Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 5, 2025 | ELTX Elicio Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 4, 2025 | ELTX Elicio Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 4, 2025 | ELTX Elicio Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jun 4, 2025 | ELTX Elicio Therapeutics, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jun 4, 2025 | ELTX Elicio Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 20, 2025 | ELTX Elicio Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 13, 2025 | ELTX Elicio Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 31, 2025 | ELTX Elicio Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 24, 2025 | ELTX Elicio Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 5, 2025 | ELTX Elicio Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jan 30, 2025 | ELTX Elicio Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 30, 2025 | ELTX Elicio Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 23, 2025 | ELTX Elicio Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 22, 2025 | ELTX Elicio Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 12, 2024 | ELTX Elicio Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 12, 2024 | ELTX Elicio Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 3, 2024 | ELTX Elicio Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 21, 2024 | ELTX Elicio Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Nov 13, 2024 | ELTX Elicio Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 7, 2024 | ELTX Elicio Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 7, 2024 | ELTX Elicio Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
40 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:37 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances